MARATTO

article · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences

Investigating Nitrogen Containing Compounds as Promising Anticancer Agents

2024Open accessSuez Canal University

Abstract

Cancer is known as a large group of diseases with one shared thing that normal cells become cancerous cells which speedily multiply then spread. Colorectal cancer is the one of top two most common cause of death worldwide. Most Chemotherapy drugs can badly damage vital human organs so medicines are prescribed with the chemotherapy for the protection of body normal cells. New targets for cancer treatment have been over years to help discover new drugs with higher potency and lower side effects. New thiazole based compounds can be developed by reacting various chemical scaffolds are considered promising anti-cancer agents. They are reported with the inhibitory effect on different kinases including epidermal growth factor receptor (EGFR) that play a main role in cancerous cell growth, proliferation and metastasis through the transmission of cellular signaling. Molecular docking analyses were performed to assess the binding affinities and interaction patterns of the compounds within the active site of EGFR. Furter, in silico toxicity and target interaction predictions were carried out for the five compounds using the ProTox 3.0 platform.

Research topics

  • Chemical Reactions and Isotopes
  • Synthesis and biological activity

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/rpbs.2025.402080.1386

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.